AstraZeneca Says Zinforo Obtains Positive CHMP Opinion In EU – Quick Facts – NASDAQ

( – AstraZeneca Plc (AZN, AZN.L) announced that the Committee for Medicinal Products for Human Use, or CHMP, has adopted a positive opinion, recommending the approval of Zinforo (ceftaroline fosamil), a new intravenous cephalosporin …

Leave a Reply

Your email address will not be published.